Management of pembrolizumab-induced steroid refractory mucositis with infliximab: A case report

doi:10.12998/wjcc.v8.i18.4100

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 18

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5382)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

372

WORD

156

HTML

2773

Figures (1-3)

481

Sum=3782

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

624

Download

976

Sum=1600

Sep 26, 2020 (publication date) through Jul 20, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Sep 26, 2020; 8(18): 4100-4108
Published online Sep 26, 2020. doi: 10.12998/wjcc.v8.i18.4100

Full Size Figure Download Figure

Figure 2 HE stain of larynx biopsy results. A: Larynx, right arytenoid tissue: Fibrinopurulent exudation; B: Larynx, left false vocal cord: Granulation tissue. HE stain of larynx biopsy (× 400).

Citation: Dang H, Sun J, Wang G, Renner G, Layfield L, Hilli J. Management of pembrolizumab-induced steroid refractory mucositis with infliximab: A case report. World J Clin Cases 2020; 8(18): 4100-4108
URL: https://www.wjgnet.com/2307-8960/full/v8/i18/4100.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i18.4100